1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ghana Pharmaceuticals and Healthcare Report Q3 2016

Ghana Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 89 pages

Includes 3 FREE quarterly updates

BMI View: The Ghanaian government will retain its support towards domestic pharmaceuticalmanufacturers in the country, in hope of achieving status as the Economic Communities of West AfricanStates' hub for pharmaceutical and healthcare investment. Larger domestic manufacturers will look to gainWHO and GMP certification, allowing Ghana to reduce its unsustainable reliance on imports. However,local manufacturers will continue to be challenged by their global competitiveness against Asiandrugmakers who are often able to provide cheaper medicines. The long-term success of Ghana's NationalHealth Insurance Scheme will largely be determined by sustained financial support, as well asimprovements to Ghana's healthcare system on a national-scale.Headline Expenditure ProjectionsPharmaceuticals: GHS1.18bn (USD310mn) in 2015 to GHS1.36bn (USD340mn) in 2016; +15.9% in localcurrency terms and +8.9% in US dollar terms. Forecast unchanged from Q216.Healthcare: GHS4.49bn (USD1.19bn) in 2015 to GHS4.97bn (USD1.24bn) in 2016; +10.9% in localcurrency terms and +4.1% in US dollar terms. Forecast in line with Q216.

Table Of Contents

Ghana Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ghana 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ghana 2012-2020) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 21
Prescription Drug Market Forecast 22
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 26
Generic Drug Market Forecast 27
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 28
OTC Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Ghana 2014-2020) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (Ghana 2014-2020) 34
Industry Risk/Reward Index 35
Middle East and Africa Risk/Reward Index - Q3 2016 35
Ghana Risk/Reward Index 43
Rewards 43
Risks 44
Regulatory Review 46
Intellectual Property Issues 48
Pricing And Reimbursement Regime 48
Market Overview 51
Healthcare Sector 52
Table: Healthcare Resources (Ghana 2010-2015) 56
Table: Healthcare Personnel (Ghana 2010-2015) 56
Table: Healthcare Activity (Ghana 2010-2015) 57
Research and Development 57
Clinical Trials 57
Epidemiology 59
Competitive Landscape 65
Research-Based Industry 65
Table: Multinational Market Activity 68
Generic Drugmakers 68
Pharmaceutical Distribution 69
Pharmaceutical Retail Sector 69
Company Profile 71
Ayrton Drug Manufacturing Company (Adcock Ingram) 71
Danadams 74
Demographic Forecast 78
Table: Population Headline Indicators (Ghana 1990-2025) 79
Table: Key Population Ratios (Ghana 1990-2025) 79
Table: Urban/Rural Population and Life Expectancy (Ghana 1990-2025) 80
Table: Population By Age Group (Ghana 1990-2025) 80
Table: Population By Age Group % (Ghana 1990-2025) 81
Glossary 83
Methodology 85
Pharmaceutical Expenditure Forecast Model 85
Healthcare Expenditure Forecast Model 85
Notes On Methodology 86
Risk/Reward Index Methodology 87
Index Overview 88
Table: Pharmaceutical Risk/Reward Index Indicators 88
Indicator Weightings 89

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.